Patient explainer · Learn
Cancer Prevention
The Intersection of Longevity Medicine and Cancer Prevention
This is a detailed subject, and what it means for your situation depends on your history and your imaging. Dr. Glowney is glad to work through it with you.
Cancer development and risk.
Cancer is a critical focus within longevity medicine, as it is both a leading cause of death and a significant barrier to achieving extended healthspans. Longevity medicine emphasizes early detection, prevention, and care tailored to each person's cancer risk. This approach draws on genetics, lifestyle factors, and, when there is a clinical reason, advanced testing.
Cancer occurs when cells grow uncontrollably due to genetic and epigenetic changes, environmental exposures, and disruptions in the body's regulatory mechanisms. These changes can result in tumor formation and, in some cases, metastasis. As individuals age, the risk of cancer increases due to the accumulation of genetic mutations, a weakened immune system, and chronic inflammation, all of which are hallmarks of aging. Preventing and managing cancer is therefore central to healthspan.
The most prevalent cancers in the population vary by sex and geographic region, but they typically include lung, breast, colorectal, prostate, and skin cancers. Lung cancer remains the leading cause of cancer-related deaths globally, with smoking being the most significant risk factor. Breast cancer is the most common cancer in women, with hormonal, lifestyle, and genetic factors such as BRCA1 and BRCA2 mutations contributing to risk (Momenimovahed & Salehiniya, 2019; Kuchenbaecker et al., 2017). Prostate cancer is prevalent among men, often linked to age, genetics, and hormonal factors. Colorectal cancer affects both sexes and is closely tied to dietary habits, chronic inflammation, and genetic syndromes like Lynch syndrome (Keum & Giovannucci, 2019; Peltomäki et al., 2023). Skin cancers, including melanoma, are heavily influenced by ultraviolet radiation exposure and genetic predispositions.
Genetic predisposition contributes to the development of many cancers, and advances in genomics have provided significant insights into these risks. Mutations in specific genes can significantly increase the likelihood of developing cancer. For instance, mutations in the BRCA1 and BRCA2 genes are known to increase the risk of breast and ovarian cancer. Integrating these genetic insights with a comprehensive understanding of lifestyle factors, environmental exposures, and biological mechanisms underlying cancer development is essential for designing effective prevention and early intervention strategies.
Detection and prevention research.
The field of longevity medicine has made significant strides in understanding the complex nature of cancer and its relationship to aging. Using advances in diagnostics, personalized medicine, and targeted therapies, longevity medicine aims to give people the knowledge and tools to manage their cancer risk. As the global burden of cancer grows, bringing longevity medicine principles into clinical practice and public health may help prevent and manage cancer more effectively.
New cancer detection and prevention methods are also being developed. Care tailored to a person's genetic risk and lifestyle aims to lower cancer risk.
Cancer prevention is an active area of longevity research.
References
Sources cited.
- Keum, N., & Giovannucci, E. (2019). Global burden of colorectal cancer: Emerging trends, risk factors and prevention strategies. Nature Reviews Gastroenterology & Hepatology, 16(12), 713–732. https://doi.org/10.1038/s41575-019-0189-8
- Kuchenbaecker, K. B., Hopper, J. L., Barnes, D. R., Phillips, K. A., Mooij, T. M., Roos-Blom, M. J., Jervis, S., van Leeuwen, F. E., Milne, R. L., Andrieu, N., Goldgar, D. E., Terry, M. B., Rookus, M. A., Easton, D. F., Antoniou, A. C., BRCA1 and BRCA2 Cohort Consortium, McGuffog, L., Evans, D. G., Barrowdale, D., ... Olsson, H. (2017). Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA, 317(23), 2402–2416. https://doi.org/10.1001/jama.2017.7112
- Momenimovahed, Z., & Salehiniya, H. (2019). Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer: Targets and Therapy, 11, 151–164. https://doi.org/10.2147/BCTT.S176070
- Peltomäki, P., Nyström, M., Mecklin, J. P., & Seppälä, T. T. (2023). Lynch syndrome genetics and clinical implications. Gastroenterology, 164(5), 783–799. https://doi.org/10.1053/j.gastro.2022.08.058
Related patient explainers